A drug with the SMILES CCn1cnc2sc(C(=O)N3CCN(Cc4ccc5c(c4)OCO5)CC3)c(C)c2c1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 6.414%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCn1cnc2sc(C(=O)N3CCN(Cc4ccc5c(c4)OCO5)CC3)c(C)c2c1=O
CCn1cnc2sc(C(=O)N3CCN(Cc4ccc5c(c4)OCO5)CC3)c(C)c2c1=O
6-[4-(1,3-benzodioxol-5-ylmethyl)piperazine-1-carbonyl]-3-ethyl-5-methylthieno[2,3-d]pyrimidin-4-one